To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.

6/25/2026, 8:08 AM

Summary of Bill HR 9421

H.R. 9421, introduced in the 119th Congress on June 24, 2026, aims to restrict REMS-certified providers from prescribing mifepristone without both an in-person visit and a valid medical license in the patient's residing state, among other purposes.

Current Status of Bill HR 9421

Bill HR 9421 is currently in the status of Bill Introduced since June 24, 2026. Bill HR 9421 was introduced during Congress 119 and was introduced to the House on June 24, 2026. Bill HR 9421's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 24, 2026

Bipartisan Support of Bill HR 9421

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9421

Primary Policy Focus

Alternate Title(s) of Bill HR 9421

To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.